Transpire Bio announces agreement with INTO for the development of three inhaled medicines

News Transpire Bio announces agreement with INTO for the development of three inhaled medicines WESTON, Fla., July 7, 2025 (GLOBE NEWSWIRE) Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has today announced a definitive agreement with INTO (Inhalation Together) to develop TRB-5, TRB-6 and TRB-7, inhaled medicines […]